As a novel checkpoint inhibitor, TTI-621 (SIRPα-IgG1 Fc) is a soluble, fully human recombinant fusion protein designed to block the CD47 “do not eat me” signal by IFN primed macrophages that triggers tumor cell phagocytosis. The gene discussed is SIRPA; the disease is neoplasm.